Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian Morecroft

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Circulation|July 18, 2002
Is the pregnancy hormone relaxin also a vasodilator peptide secreted by the heart?Carol Fisher, Margaret MacLean, Ian Morecroft, et al.
Pulmonary Circulation|July 10, 2014
Transient but not genetic loss of miR-451 is protective in the development of pulmonary arterial hypertensionJennifer S Grant, Ian Morecroft, Yvonne Dempsie, et al.
European Journal of Pharmacology|April 25, 2006
The in vivo effects of human urotensin II in the rabbit and rat pulmonary circulation: effects of experimental pulmonary hypertensionGraeme A Deuchar, Ian Morecroft, Yvonne Dempsie, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 22, 2005
Functional interactions between 5-hydroxytryptamine receptors and the serotonin transporter in pulmonary arteriesIan Morecroft, Lynn Loughlin, Margaret Nilsen, et al.
Cardiovascular Research|September 9, 2009
In vivo effects of a combined 5-HT1B receptor/SERT antagonist in experimental pulmonary hypertensionIan Morecroft, Louisa Pang, Marta Baranowska, et al.
Hypertension (Dallas, Tex. : 1979)|November 30, 2006
Effect of tryptophan hydroxylase 1 deficiency on the development of hypoxia-induced pulmonary hypertensionIan Morecroft, Yvonne Dempsie, Michael Bader, et al.
Cardiovascular Research|March 23, 2013
Dexfenfluramine and the oestrogen-metabolizing enzyme CYP1B1 in the development of pulmonary arterial hypertensionYvonne Dempsie, Neil A MacRitchie, Kevin White, et al.
Circulation Research|February 25, 2006
Serotonin increases susceptibility to pulmonary hypertension in BMPR2-deficient miceLu Long, Margaret R MacLean, Trina K Jeffery, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 25, 2012
Gene therapy by targeted adenovirus-mediated knockdown of pulmonary endothelial Tph1 attenuates hypoxia-induced pulmonary hypertensionIan Morecroft, Katie White, Paola Caruso, et al.
Pulmonary Circulation|May 11, 2016
The serotonin transporter promotes a pathological estrogen metabolic pathway in pulmonary hypertension via cytochrome P450 1B1Anne Katrine Z Johansen, Afshan Dean, Ian Morecroft, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Circulation|July 18, 2002
Is the pregnancy hormone relaxin also a vasodilator peptide secreted by the heart?Carol Fisher, Margaret MacLean, Ian Morecroft, et al.
Pulmonary Circulation|July 10, 2014
Transient but not genetic loss of miR-451 is protective in the development of pulmonary arterial hypertensionJennifer S Grant, Ian Morecroft, Yvonne Dempsie, et al.
European Journal of Pharmacology|April 25, 2006
The in vivo effects of human urotensin II in the rabbit and rat pulmonary circulation: effects of experimental pulmonary hypertensionGraeme A Deuchar, Ian Morecroft, Yvonne Dempsie, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 22, 2005
Functional interactions between 5-hydroxytryptamine receptors and the serotonin transporter in pulmonary arteriesIan Morecroft, Lynn Loughlin, Margaret Nilsen, et al.
Cardiovascular Research|September 9, 2009
In vivo effects of a combined 5-HT1B receptor/SERT antagonist in experimental pulmonary hypertensionIan Morecroft, Louisa Pang, Marta Baranowska, et al.
Hypertension (Dallas, Tex. : 1979)|November 30, 2006
Effect of tryptophan hydroxylase 1 deficiency on the development of hypoxia-induced pulmonary hypertensionIan Morecroft, Yvonne Dempsie, Michael Bader, et al.
Cardiovascular Research|March 23, 2013
Dexfenfluramine and the oestrogen-metabolizing enzyme CYP1B1 in the development of pulmonary arterial hypertensionYvonne Dempsie, Neil A MacRitchie, Kevin White, et al.
Circulation Research|February 25, 2006
Serotonin increases susceptibility to pulmonary hypertension in BMPR2-deficient miceLu Long, Margaret R MacLean, Trina K Jeffery, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 25, 2012
Gene therapy by targeted adenovirus-mediated knockdown of pulmonary endothelial Tph1 attenuates hypoxia-induced pulmonary hypertensionIan Morecroft, Katie White, Paola Caruso, et al.
Pulmonary Circulation|May 11, 2016
The serotonin transporter promotes a pathological estrogen metabolic pathway in pulmonary hypertension via cytochrome P450 1B1Anne Katrine Z Johansen, Afshan Dean, Ian Morecroft, et al.
Pageof 2